SYNTA PHARMACEUTICALS CORP 4
4 · SYNTA PHARMACEUTICALS CORP · Filed Jan 5, 2016
Insider Transaction Report
Form 4
Morenstein Scott D
Director
Transactions
- Award
Common Stock
2016-01-01+17,857→ 17,857 total
Footnotes (1)
- [F1]Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 50% of the shares on each of March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date.